May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Amniotic Membrane Transplantation for the Treatment of Rheumatoid Arthritis–Associated Corneal Ulcers
Author Affiliations & Notes
  • P.M. Prahs
    Ophthalmology, University of Regensburg, Regensburg, Germany
  • W. Herrmann
    Ophthalmology, University of Regensburg, Regensburg, Germany
  • K. Hufendiek
    Ophthalmology, University of Regensburg, Regensburg, Germany
  • V.–P. Gabel
    Ophthalmology, University of Regensburg, Regensburg, Germany
  • Footnotes
    Commercial Relationships  P.M. Prahs, None; W. Herrmann, None; K. Hufendiek, None; V. Gabel, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 3950. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P.M. Prahs, W. Herrmann, K. Hufendiek, V.–P. Gabel; Amniotic Membrane Transplantation for the Treatment of Rheumatoid Arthritis–Associated Corneal Ulcers . Invest. Ophthalmol. Vis. Sci. 2006;47(13):3950.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the efficacy of amniotic membrane transplantation for the treatment of corneal ulcers in patients with rheumatoid arthritis.

Methods: : In a retrospective study 9 eyes of 7 consecutive patients with corneal ulcers associated with rheumatoid arthritis were evaluated. In all patients a peripheral corneal ulcer extending 80–90% of stromal thickness resistant to conventional therapy was treated with an amniotic membrane transplantation. The corneal defects were filled with an amniotic membrane graft and an amniotic membrane patch was applied over the whole cornea (sandwich technique). Additionally all patients continued conservative treatment including systemic steroids. Clinical success was defined as healing of the ulcer 3 months after surgery.

Results: : Epithelial closure over the implanted graft was achieved in 6 of 9 eyes (66%) after a mean time of 25 days (range 18–31 days, SD ± 6,7) and remained closed over a minimum of 3 months. In one patient the procedure had to be repeated due to the loss of the transplant in the postoperative period. Epithelial closure was observed after the second surgery. In a severe case penetrating keratoplasty was necessary in both eyes due to progression of systemic disease resulting in corneal perforation.

Conclusions: : The results of this case series indicate that amniotic membrane transplantation is an effective option for treatment of corneal ulcers in patients with rheumatoid arthritis resistant to conservative therapy.

Keywords: cornea: clinical science • wound healing • autoimmune disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×